The PE Ratio as of December 2025 (TTM) for Kilitch Drugs (India) Limited (KILITCH.BO) is 20.28

According to Kilitch Drugs (India) Limited’s latest financial reports and current stock price. The company's current PE Ratio is 20.28. This represents a change of -26.72% compared to the average of 27.68 of the last 4 quarters.

Kilitch Drugs (India) Limited (KILITCH.BO) Historical PE Ratio (quarterly & annually)

How has KILITCH.BO PE Ratio performed in the past?

The mean historical PE Ratio of Kilitch Drugs (India) Limited over the last ten years is 38.68. The current 20.28 PE Ratio has changed 5.14% with respect to the historical average. Over the past ten years (40 quarters), KILITCH.BO's PE Ratio was at its highest in in the March 2019 quarter at 149.98. The PE Ratio was at its lowest in in the June 2019 quarter at -282.88.

Kilitch Drugs (India) Limited (KILITCH.BO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Kilitch Drugs (India) Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kilitch Drugs (India) Limited (KILITCH.BO) Average PE Ratio

How has KILITCH.BO PE Ratio performed in the past?

The current PE Ratio of Kilitch Drugs (India) Limited (KILITCH.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kilitch Drugs (India) Limited (KILITCH.BO) PE Ratio vs. Peers

How is KILITCH.BO’s PE Ratio compared to its peers?

Kilitch Drugs (India) Limited’s PE Ratio is greater than Venus Remedies Limited (18.67), greater than Venus Remedies Limited (18.67), greater than Ind-Swift Laboratories Limited (2.76), greater than Ind-Swift Laboratories Limited (2.76), less than Medicamen Biotech Limited (58.81), less than Medicamen Biotech Limited (58.81), less than Shree Ganesh Remedies Limited (27.98), less than Prevest Denpro Limited (27.84), less than Albert David Limited (71.17), greater than Jenburkt Pharmaceuticals Limited (14.71),

Build a custom stock screener for Kilitch Drugs (India) Limited (KILITCH.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kilitch Drugs (India) Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kilitch Drugs (India) Limited (KILITCH.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kilitch Drugs (India) Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.